U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
194461194461SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue SarcomasCompletedNo Results AvailableGastrointestinal Stromal Tumor|SarcomaDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00005862
194462194462Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: pegylated liposomal doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00005861
194463194463Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNo Results AvailableCancerDrug: floxuridine|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005860
194464194464Tipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005859
194465194465LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian CancerCompletedNo Results AvailableBladder Cancer|Breast Cancer|Colorectal Cancer|Lung Cancer|Ovarian Cancer|Pancreatic CancerBiological: LMB-9 immunotoxinhttps://ClinicalTrials.gov/show/NCT00005858
194466194466Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNo Results AvailableProstate CancerBiological: trastuzumab|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00005857
194467194467Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTerminatedNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult GliosarcomaDrug: oxaliplatin|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00005856
194468194468Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: carmustine|Drug: efaproxiralhttps://ClinicalTrials.gov/show/NCT00005855
194469194469Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesDrug: cyclophosphamide|Drug: cyclosporine|Drug: methotrexate|Procedure: allogeneic bone marrow transplantation|Procedure: in vitro-treated bone marrow transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005854
194470194470Biological Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesBiological: anti-thymocyte globulin|Biological: etanercepthttps://ClinicalTrials.gov/show/NCT00005853
194471194471Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantTerminatedNo Results AvailableChronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesBiological: anti-thymocyte globulin|Biological: filgrastim|Biological: muromonab-CD3|Drug: cyclophosphamide|Drug: cyclosporine|Drug: methylprednisolone|Procedure: allogeneic bone marrow transplantationhttps://ClinicalTrials.gov/show/NCT00005852
194472194472Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney CancerActive, not recruitingNo Results AvailableRecurrent Renal Cell Cancer|Stage IV Renal Cell CancerDrug: fludarabine phosphate|Radiation: total-body irradiation|Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation|Drug: cyclosporine|Drug: mycophenolate mofetil|Procedure: peripheral blood stem cell transplantation|Biological: therapeutic allogeneic lymphocytes|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00005851
194473194473Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNo Results AvailableAnxiety Disorder|Depression|Fatigue|Lung CancerDrug: cisplatin|Drug: fluoxetine|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00005850
194474194474Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: bryostatin 1|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00005849
194475194475R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNo Results AvailableProstate CancerDrug: chemotherapy|Drug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005848
194476194476Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNo Results AvailableProstate CancerBiological: recombinant interferon alfa|Drug: estramustine phosphate sodium|Drug: isotretinoin|Drug: mitoxantrone hydrochloride|Drug: paclitaxel|Drug: vinorelbine ditartratehttps://ClinicalTrials.gov/show/NCT00005847
194477194477Tipifarnib in Treating Patients With Myeloproliferative DisordersActive, not recruitingNo Results AvailableLeukemia|Myelodysplastic/Myeloproliferative NeoplasmsDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005846
194478194478Tipifarnib in Treating Patients With Myelodysplastic SyndromesCompletedNo Results AvailableChronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed SideDrug: tipifarnib|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00005845
194479194479Oxaliplatin in Treating Children With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Childhood Solid Tumor, Protocol SpecificDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005844
194480194480R115777 in Treating Patients Who Have Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005843
194481194481Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerCompletedNo Results AvailableCancerBiological: trastuzumab|Drug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00005842
194482194482Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaTerminatedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Biological: MART-1 antigen|Biological: gp100 antigen|Biological: incomplete Freund's adjuvant|Biological: progenipoietin|Biological: tyrosinase peptidehttps://ClinicalTrials.gov/show/NCT00005841
194483194483Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNo Results AvailableEndometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer|Stage IV Uterine Corpus CancerDrug: Paclitaxel|Drug: Cisplatin|Radiation: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00005840
194484194484Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: capecitabine|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005839
194485194485Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNo Results AvailableAdenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung CancerDrug: shark cartilage extract AE-941|Other: placebo|Drug: cisplatin|Drug: vinorelbine tartrate|Drug: carboplatin|Drug: paclitaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005838
194486194486Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNo Results AvailableCervical CancerDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005837
194487194487Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based ChemotherapyCompletedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00005836
194488194488N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Recurrent NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaDrug: buthionine sulfoximine|Drug: melphalan|Procedure: Peripheral blood stem cell infusion|Other: Filgrastimhttps://ClinicalTrials.gov/show/NCT00005835
194489194489S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaBiological: filgrastim|Drug: cisplatin|Drug: cyclophosphamide|Drug: dexamethasone|Drug: etoposide|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00005834
194490194490S9923 R115777 in Treating Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: R115777https://ClinicalTrials.gov/show/NCT00005833

* Görseller ve İçerik tekif hakkına sahip olabilir